{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:18:47Z","timestamp":1792091927221,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":5840,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2000]]},"DOI":"10.1111\/j.1469-0691.2000.tb02047.x","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T05:10:00Z","timestamp":1413349800000},"page":"64-69","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["The new oral cephalosporins in community-acquired infections"],"prefix":"10.1016","volume":"6","author":[{"given":"D.E.","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.96.4.758","volume":"96","author":"Dajani","year":"1995","journal-title":"Pediatrics"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0022-3476(87)80024-0","article-title":"Efficacy of benzathine penicillin G in group A streptococcal pharyngitis: reevaluation","volume":"110","author":"Feldman","year":"1987","journal-title":"J Pediatr"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(80)91832-2","article-title":"Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis","volume":"ii","author":"Gastanaduy","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00006454-198611000-00010","article-title":"Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis","volume":"5","author":"Stillerman","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/00365549409008592","article-title":"Five versus ten days treatment of streptococcal pharyngotonsillitis: a randomized controlled trial comparing cefpodoxime proxetil and phenoxymethyl penicillin","volume":"26","author":"Portier","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib6","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archpedi.1994.02170100051010","article-title":"Effective short-course treatment of acute group A beta-hemolytic streptococcal tonsillopharyngitis. Ten days of penicillin V vs 5 days or 10 days of cefpodoxime therapy in children","volume":"148","author":"Pichichero","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006454-199104000-00002","article-title":"A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity","volume":"10","author":"Pichichero","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/00365549509019013","article-title":"Is penicillin the appropriate treatment for recurrent tonsillopharyngitis? Results from a comparative randomized blind study of cefuroxime axetil and phenoxymethylpenicillin in children. The Swedish Study Group","volume":"27","author":"Holm","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199401000-00002","article-title":"Streptococcal pharyngitis: the case for penicillin therapy","volume":"13","author":"Shulman","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/infdis\/166.6.1346","article-title":"The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio","volume":"166","author":"Reichler","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/0140-6736(92)91868-9","article-title":"Increasing penicillin resistance in pneumococci in Iceland","volume":"339","author":"Kristinsson","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/infdis\/164.2.302","article-title":"Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae","volume":"164","author":"Munoz","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.1996.03530270015006","article-title":"Icelandic researchers are showing the way to bring down rates of antibiotic-resistant bacteria","volume":"275","author":"Stephenson","year":"1996","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/clinids\/15.1.77","article-title":"Antimicrobial resistance in Streptococcus pneumoniae: an overview","volume":"15","author":"Appelbaum","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"Suppl. 4","key":"10.1111\/j.1469-0691.2000.tb02047.x_bib15","first-page":"7","article-title":"Antibiotic-resistant pneumococci \u2013 facts and fiction","volume":"6","author":"Appelbaum","year":"1994","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00006454-199505001-00005","article-title":"Treatment guidelines for otitis media: the need for breadth and flexibility","volume":"14","author":"Paradise","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib17","series-title":"Antimicrobial Therapy and Vaccines","first-page":"703","article-title":"Cephalosporins: Oral","author":"Bryskier","year":"1998"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00006454-199611000-00010","article-title":"Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin","volume":"15","author":"Dagan","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/AAC.42.3.589","article-title":"Prevalence of antimicrobial-resistant pathogens in middle ear fluid; multinational study of 917 children with acute otitis media","volume":"42","author":"Jacobs","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00006454-199701000-00020","article-title":"Penetration of cefpodoxime into middle ear fluid in pediatric patients with acute otitis media","volume":"16","author":"van Dyk","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365549409011816","article-title":"Twice daily cefpodoxime proxetil compared with thrice daily amoxicillin\/clavulanic acid for treatment of acute otitis media in children","volume":"26","author":"Gehanno","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jac\/41.2.207","volume":"41","author":"Richard","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib23","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.279.21.1736","article-title":"Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis","volume":"279","author":"Kozyrskyj","year":"1998","journal-title":"JAMA"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0022-3476(98)70103-9","article-title":"A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children","volume":"133","author":"Cohen","year":"1998","journal-title":"J Pediatr"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","article-title":"New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases","volume":"69","author":"Fang","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/infdis\/144.2.101","article-title":"Haemophilus influenzae infection in adults: characterization of strains by serotypes, biotypes, and beta-lactamase production","volume":"144","author":"Wallace","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/BF01973988","article-title":"Prospective epidemiological study of invasive Haemophilus influenzae disease in adults","volume":"13","author":"Deulofeu","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib28","series-title":"Abstracts of 36th Interscience Conference of Antimicrobiol Agents and Chemotherapy","article-title":"Serotype characterization of Haemophilus influenzae isolates causing invasive disease in Canada following the introduction of Hib vaccines","author":"Petrof","year":"1996"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1542\/peds.99.2.289","article-title":"Therapy for children with invasive pneumococcal infections. American Academy of Pediatrics Committee on Infectious Diseases","volume":"99","author":"Anonymous","year":"1997","journal-title":"Pediatrics"},{"issue":"Suppl. 2","key":"10.1111\/j.1469-0691.2000.tb02047.x_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00003495-199600522-00009","article-title":"Epidemiology, control and treatment of multiresistant pneumococci","volume":"52","author":"Klugman","year":"1996","journal-title":"Drugs"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib31","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(05)62222-2","article-title":"30 years of penicillin-resistant S. pneumoniae: myth or reality?","volume":"350","author":"Goldstein","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1099\/00222615-43-4-237","article-title":"Therapy for penicillin-resistant Streptococcus pneumoniae","volume":"43","author":"Strachan","year":"1995","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/00365549709019038","article-title":"Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae","volume":"29","author":"Goldstein","year":"1997","journal-title":"Scand J Infect Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0732-8893(96)00162-9","article-title":"Antimicrobial resistance issues of the future","volume":"25","author":"Craig","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl. 3","key":"10.1111\/j.1469-0691.2000.tb02047.x_bib35","first-page":"38","article-title":"Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections","volume":"9","author":"Drusano","year":"1997","journal-title":"J Chemother"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/mdr.1995.1.43","article-title":"New prospects for antibacterial agents against multidrug-resistant pneumococci","volume":"1","author":"Appelbaum","year":"1995","journal-title":"Microb Drug Resist"},{"issue":"Suppl. E","key":"10.1111\/j.1469-0691.2000.tb02047.x_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/26.suppl_E.13","article-title":"The pharmacokinetics of the oral cephalosporins-a review","volume":"26","author":"Wise","year":"1990","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00007435-199810000-00004","article-title":"Clinical evaluation of ceftibuten in gonorrhea. A pilot study in Hong Kong","volume":"25","author":"Chong","year":"1998","journal-title":"Sex Transm Dis"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00007435-199809000-00008","article-title":"Neisseria gonorrhoeae resistant to ciprofloxacin and ofloxacin","volume":"25","author":"Knapp","year":"1998","journal-title":"Sex Transm Dis"},{"issue":"Suppl. 1","key":"10.1111\/j.1469-0691.2000.tb02047.x_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000048460","article-title":"Cefixime for switch therapy","volume":"44","author":"Hamilton-Miller","year":"1998","journal-title":"Chemotherapy"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/archinte.1995.00430120050006","article-title":"Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia","volume":"155","author":"Ramirez","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib42","first-page":"352","article-title":"Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil","volume":"19","author":"Bauemfeind","year":"1991","journal-title":"Infection"},{"key":"10.1111\/j.1469-0691.2000.tb02047.x_bib43","first-page":"127","article-title":"An in vitro characterization of cefditoren, a new oral cephalosporin","volume":"20","author":"Felmingham","year":"1994","journal-title":"Drugs Exp Clin Res"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15302810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15302810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T20:09:39Z","timestamp":1650398979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15302810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"references-count":43,"alternative-id":["S1198743X15302810"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2000.tb02047.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2000]]}}}